Literature DB >> 9767056

Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.

E Y Denkers1, R T Gazzinelli.   

Abstract

The intracellular protozoan Toxoplasma gondii is a widespread opportunistic parasite of humans and animals. Normally, T. gondii establishes itself within brain and skeletal muscle tissues, persisting for the life of the host. Initiating and sustaining strong T-cell-mediated immunity is crucial in preventing the emergence of T. gondii as a serious pathogen. The parasite induces high levels of gamma interferon (IFN-gamma) during initial infection as a result of early T-cell as well as natural killer (NK) cell activation. Induction of interleukin-12 by macrophages is a major mechanism driving early IFN-gamma synthesis. The latter cytokine, in addition to promoting the differentiation of Th1 effectors, is important in macrophage activation and acquisition of microbicidal functions, such as nitric oxide release. During chronic infection, parasite-specific T lymphocytes release high levels of IFN-gamma, which is required to prevent cyst reactivation. T-cell-mediated cytolytic activity against infected cells, while easily demonstrable, plays a secondary role to inflammatory cytokine production. While part of the clinical manifestations of toxoplasmosis results from direct tissue destruction by the parasite, inflammatory cytokine-mediated immunopathologic changes may also contribute to disease progression.

Entities:  

Mesh:

Year:  1998        PMID: 9767056      PMCID: PMC88897          DOI: 10.1128/CMR.11.4.569

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  227 in total

1.  In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.

Authors:  T M Scharton-Kersten; T A Wynn; E Y Denkers; S Bala; E Grunvald; S Hieny; R T Gazzinelli; A Sher
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

Review 2.  Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.

Authors:  G Trinchieri
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

3.  Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.

Authors:  H C Bucher; L Griffith; G H Guyatt; M Opravil
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-06-01

4.  Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.

Authors:  R T Gazzinelli; S Hieny; T A Wynn; S Wolf; A Sher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

5.  Effect of the strain of Toxoplasma gondii on the development of toxoplasmic encephalitis in mice treated with antibody to interferon-gamma.

Authors:  Y Suzuki; K Joh
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

6.  Toxoplasma gondii infection induces specific nonresponsiveness in lymphocytes bearing the V beta 5 chain of the mouse T cell receptor.

Authors:  E Y Denkers; P Caspar; S Hieny; A Sher
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422

7.  Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis.

Authors:  C A Hunter; C W Roberts; J Alexander
Journal:  Eur J Immunol       Date:  1992-09       Impact factor: 5.532

8.  Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients.

Authors:  B A Navia; C K Petito; J W Gold; E S Cho; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

9.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.

Authors:  M Kobayashi; L Fitz; M Ryan; R M Hewick; S C Clark; S Chan; R Loudon; F Sherman; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

10.  Toxoplasma gondii possesses a superantigen activity that selectively expands murine T cell receptor V beta 5-bearing CD8+ lymphocytes.

Authors:  E Y Denkers; P Caspar; A Sher
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  245 in total

1.  Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments.

Authors:  F Velge-Roussel; P Marcelo; A C Lepage; D Buzoni-Gatel; D T Bout
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Neutrophil depletion during Toxoplasma gondii infection leads to impaired immunity and lethal systemic pathology.

Authors:  S K Bliss; L C Gavrilescu; A Alcaraz; E Y Denkers
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Genetic approaches to studying virulence and pathogenesis in Toxoplasma gondii.

Authors:  L David Sibley; Dana G Mordue; Chunlei Su; Paul M Robben; Dan K Howe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-01-29       Impact factor: 6.237

4.  Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis.

Authors:  N Schöler; K Krause; O Kayser; R H Müller; K Borner; H Hahn; O Liesenfeld
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

5.  Microbial infection-induced expansion of effector T cells overcomes the suppressive effects of regulatory T cells via an IL-2 deprivation mechanism.

Authors:  Alicia Benson; Sean Murray; Prashanthi Divakar; Nikolay Burnaevskiy; Reed Pifer; James Forman; Felix Yarovinsky
Journal:  J Immunol       Date:  2011-12-05       Impact factor: 5.422

6.  Mechanism of entry determines the ability of Toxoplasma gondii to inhibit macrophage proinflammatory cytokine production.

Authors:  Barbara A Butcher; Eric Y Denkers
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

Review 7.  Costimulation in resistance to infection and development of immune pathology: lessons from toxoplasma.

Authors:  Christopher A Hunter; Linda A Lieberman; Nicola Mason; Marion Pepper; Sarah L Sague; Cristina Tato; Valerie Zediak
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

8.  Long-term protective immune response elicited by vaccination with an expression genomic library of Toxoplasma gondii.

Authors:  Alberto Fachado; Alexandro Rodriguez; Judith Molina; Jaline C Silvério; Ana P M P Marino; Luzia M O Pinto; Sergio O Angel; Juan F Infante; Yara Traub-Cseko; Regina R Amendoeira; Joseli Lannes-Vieira
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Cellular immunity to Toxoplasma gondii in congenitally infected newborns and immunocompetent infected hosts.

Authors:  A F Fatoohi; G J N Cozon; M Wallon; S Kahi; F Gay-Andrieu; T Greenland; F Peyron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-04       Impact factor: 3.267

10.  Genotype analysis of T. gondii strains associated with human infection in Egypt.

Authors:  Mona Mohamed Tolba; Hend Ali El-Taweel; Safia Saleh Khalil; Walaa Ali Hazzah; Mohamed Gamal Heshmat
Journal:  Parasitol Res       Date:  2014-02-14       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.